ONIVYDE
Google image searchProduct monograph
Active ingredient
irinotecan (irinotecan sucrose octasulfate), 4.3 MG/ML
DIN: 02467135
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAVENOUS
Description: LIPOSOMES FOR INJECTION. SINGLE USE VIAL
Schedule: Prescription
Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Date: 17-AUG-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01C — PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS (ATC, ATC/DDD)
- L01CE — Topoisomerase 1 (TOP1) inhibitors (ATC, ATC/DDD)
- L01CE02 — IRINOTECAN (ATC/DDD)
Reference brand drug: Camptosar
